Yi-Chen Li Selected Research

2',7'-dichlorodihydrofluorescein diacetate

1/2020	Protective effect of combined therapy with hyperbaric oxygen and autologous adipose-derived mesenchymal stem cells on renal function in rodent after acute ischemia-reperfusion injury.
1/2020	Uremic toxic substances are essential elements for enhancing carotid artery stenosis after balloon-induced endothelial denudation: worsening role of the adventitial layer.
1/2019	Early administration of cold water and adipose derived mesenchymal stem cell derived exosome effectively protects the heart from ischemia-reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yi-Chen Li Research Topics

Disease

21	Inflammation (Inflammations) 01/2022 - 01/2017
11	Neoplasms (Cancer) 04/2022 - 05/2010
9	Fibrosis (Cirrhosis) 04/2022 - 01/2018
7	Ischemia 01/2021 - 01/2018
5	Shock 09/2021 - 01/2019
4	Heart Failure 09/2021 - 01/2018
4	Mouth Neoplasms (Oral Cancer) 01/2019 - 02/2011
3	Hemorrhage 01/2022 - 01/2019
3	Reperfusion Injury 01/2021 - 01/2018
3	Chronic Renal Insufficiency 01/2021 - 01/2019
3	Chronic Limb-Threatening Ischemia 10/2020 - 09/2018
3	Coronary Artery Disease (Coronary Atherosclerosis) 04/2020 - 01/2018
2	Sepsis-Associated Encephalopathy 08/2022 - 03/2022
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2022 - 01/2019
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 09/2021 - 01/2019
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 01/2020
2	Carcinogenesis 01/2021 - 01/2016
2	Stroke (Strokes) 02/2020 - 01/2016
2	Ischemic Stroke 02/2020 - 01/2020
2	Brain Edema (Cerebral Edema) 01/2020 - 01/2019
2	Cardio-Renal Syndrome 08/2019 - 01/2019
2	Infarction (Infarctions) 01/2019 - 01/2019
2	Brain Death (Brain Dead) 01/2019 - 01/2018
2	Periodontal Diseases (Periodontal Disease) 02/2016 - 01/2016
2	Aneurysm (Aneurysms) 07/2008 - 01/2008
1	Sepsis (Septicemia) 03/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Infections 01/2022
1	Pancreatic Fistula (Pancreatic Fistulas) 01/2022
1	Wound Infection (Wound Infections) 05/2021
1	Wounds and Injuries (Trauma) 05/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Peritoneal Fibrosis 01/2021
1	Peripheral Arterial Occlusive Disease 1 10/2020
1	Cerebral Hemorrhage 01/2020
1	Pleural Effusion (Pleural Effusions) 01/2020
1	Mediastinal Emphysema (Pneumomediastinum) 01/2020
1	Meningitis 01/2020

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 09/2021 - 03/2012
15	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2018
13	Caspase 3 (Caspase-3)IBA 09/2021 - 01/2014
8	Cytochromes c (Cytochrome c)IBA 09/2021 - 01/2018
8	Matrix Metalloproteinases (MMPs)IBA 12/2019 - 01/2013
6	MelatoninIBA 01/2021 - 01/2018
6	CollagenIBA 01/2019 - 01/2018
4	CreatinineIBA 01/2020 - 01/2018
4	CarcinogensIBA 01/2019 - 02/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2021 - 01/2019
3	Oxygen (Dioxygen)IBA 01/2021 - 01/2020
3	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 09/2013
3	2',7'-dichlorodihydrofluorescein diacetateIBA 01/2020 - 01/2019
3	NPHS2 proteinIBA 12/2019 - 01/2018
3	Therapeutic UsesIBA 04/2019 - 01/2017
2	Long Noncoding RNAIBA 08/2022 - 03/2022
2	Fibronectins (Fibronectin)IBA 04/2022 - 01/2018
2	Collagen Type IV (Type IV Collagen)IBA 04/2022 - 09/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2021 - 01/2020
2	Sitagliptin Phosphate (Januvia)FDA Link 01/2021 - 03/2019
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2021 - 03/2019
2	Cadherins (E-Cadherin)IBA 01/2021 - 01/2018
2	Coloring Agents (Dyes)IBA 01/2020 - 08/2019
2	CytokinesIBA 01/2020 - 01/2017
2	AntioxidantsIBA 01/2019 - 03/2013
2	HMGB1 Protein (HMG1)IBA 01/2019 - 01/2018
2	Mitochondrial DNA (mtDNA)IBA 01/2019 - 01/2018
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2016 - 01/2014
2	PolyphenolsIBA 03/2016 - 02/2016
1	CateninsIBA 04/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2022
1	Propofol (Diprivan)FDA LinkGeneric 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Aromatase InhibitorsIBA 01/2022
1	Internal Ribosome Entry SitesIBA 01/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	Dexmedetomidine FDA Link 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Midazolam (Versed)FDA LinkGeneric 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 05/2021
1	CurcuminIBA 04/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2021
1	Exenatide (Byetta)FDA Link 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	5- (6'- triphenylphosphoniumhexyl)- 5,6- dihydro- 6- phenyl- 3,8- phenanthridinediammineIBA 01/2020
1	NADPH Oxidase 2IBA 01/2020
1	NADPH Oxidase 1IBA 01/2020
1	4-cresol (p-cresol)IBA 01/2020

Therapy/Procedure

20	Therapeutics 04/2021 - 03/2013
3	Ligation 03/2022 - 01/2019
3	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2020 - 01/2018
3	Nephrectomy 08/2019 - 01/2019
2	Punctures 03/2022 - 01/2019
2	Hyperbaric Oxygenation 01/2021 - 10/2020
2	High-Protein Diet 08/2019 - 03/2019
2	Extracorporeal Shockwave Therapy 01/2019 - 01/2018
2	Radiotherapy 01/2019 - 01/2017
2	Stents 07/2008 - 01/2008
1	Pancreaticoduodenectomy 01/2022
1	Operative Time 05/2021
1	Peritoneal Dialysis 01/2021
1	Thrombectomy 01/2020